MedTrace Logo

Study in COPD Patients Evaluating the Quality of Life (TRISNOOZE)

NCT04611633 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2021-12-09

No results posted yet for this study

Summary

This non-interventional study aims to collect information on the patient's quality of life, as well as the quality of sleep when stepping up to a fixed triple maintenance therapy (Trimbow®) as per physicians' decision, independent from study participation, and to assess its effectiveness in daily life, in general practitioner setting.

Conditions

Interventions

COMBINATION_PRODUCT

Trimbow

As this is a non-interventional study, all treatment decisions will be made at the discretion of the treating physician prior to enrolment in the study and during the entire period of the study. Treatment will be prescribed according to the product label in the summary of product characteristics.

Sponsors & Collaborators

  • Chiesi SA/NV

    lead OTHER

Principal Investigators

  • Eric Marchand, MD, PhD · CHU Godinne UCL Namur

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2021-09-16
Completion
2021-09-16

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04611633 on ClinicalTrials.gov